NCT03914586 (MOSAKI) is a clinical trial of oXiris filter in Sepsis, sponsored by FRANCO TURANI.

Who is sponsoring NCT03914586?

NCT03914586 is sponsored by FRANCO TURANI.

What drugs are being tested in NCT03914586?

Interventions in NCT03914586: oXiris filter.

What condition does NCT03914586 study?

NCT03914586 studies Sepsis, Acute Renal Failure.

Is NCT03914586 still recruiting?

NCT03914586 is currently status unknown. Last updated 2 May 2019.

Last reviewed 2019-05-02 · How we verify

NCT03914586: MOSAKI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Membrane Adsorbing OXiris Filter in Septic Patients With AKI

Status unknown Last updated 2 May 2019

What this trial tests

trial testing oXiris filter in Sepsis in 100 participants. Status unknown.

Timeline

10 January 2019

Primary endpoint
30 December 2019

30 July 2020

Quick facts

Lead sponsor	FRANCO TURANI
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	10 January 2019
Primary completion	30 December 2019
Estimated completion	30 July 2020
Sites	1 location across Italy

Drugs / interventions tested

oXiris filter

Conditions studied

Sepsis — all drugs for Sepsis →
Acute Renal Failure — all drugs for Acute Renal Failure →

Sponsor

FRANCO TURANI

Who can join

Adults 18 to 75, any sex, with Sepsis or Acute Renal Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with Sepsis / Septic Shock and AKI are submitted to Continuous Renal Replacement Therapy with the oXiris filter . The pro- inflammatory mediators , the endotoxin , interleukin 10 , the main cardiorespiratory indices and renal parameters are evaluated at the entry of the study and at the end of the treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of oXiris filter

Trials testing the same drug.

NCT06440759 — To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT · NA · recruiting

Other recruiting trials for Sepsis

Currently open trials in the same condition.

NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03914586 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FRANCO TURANI
Last refreshed: 2 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03914586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing